CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$14.6B
(+22%)
Cap. Flow
+$971M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
365
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $23.4M | 0.16% |
417,471
+170,869
| +69% | +$9.59M |
|
152
Exxon Mobil
XOM
$477B
| $23.4M | 0.16% |
371,097
+36,577
| +11% | +$2.31M |
|
153
BioNTech
BNTX
$24.1B
| $23.3M | 0.16% |
104,097
+16,336
| +19% | +$3.66M |
|
154
Ameresco
AMRC
$1.35B
| $23.1M | 0.16% |
367,506
+118,504
| +48% | +$7.43M |
|
155
Otis Worldwide
OTIS
$33.6B
| $23M | 0.16% |
281,838
+203,163
| +258% | +$16.6M |
|
156
Netflix
NFLX
$521B
| $22.9M | 0.16% |
43,346
-1,231
| -3% | -$650K |
|
|
NUAN
157
DELISTED
Nuance Communications, Inc.
NUAN
| $22.8M | 0.16% |
418,618
+336,468
| +410% | +$18.3M |
|
158
Sherwin-Williams
SHW
$90.5B
| $22.8M | 0.16% |
83,599
+65,612
| +365% | +$8.07M |
|
|
GRA
159
DELISTED
W.R. Grace & Co.
GRA
| $22.5M | 0.15% |
325,773
+285,584
| +711% | +$19.7M |
|
160
Power Integrations
POWI
$2.46B
| $22.5M | 0.15% |
273,787
+69,852
| +34% | +$5.73M |
|
161
Parker-Hannifin
PH
$94.8B
| $22.3M | 0.15% |
72,603
+18,191
| +33% | +$5.59M |
|
162
Ionis Pharmaceuticals
IONS
$9.64B
| $22M | 0.15% |
552,566
+305,612
| +124% | +$12.2M |
|
163
Fate Therapeutics
FATE
$115M
| $21.8M | 0.15% |
250,737
-19,370
| -7% | -$1.68M |
|
164
Elevance Health
ELV
$72.4B
| $21.7M | 0.15% |
56,851
-10,821
| -16% | -$4.13M |
|
165
Southern Copper
SCCO
$82B
| $21.4M | 0.15% |
332,700
+244,700
| +278% | +$15.7M |
|
166
Interpublic Group of Companies
IPG
$9.69B
| $21.3M | 0.15% |
656,238
+418,638
| +176% | +$13.6M |
|
167
Broadcom
AVGO
$1.42T
| $21.3M | 0.15% |
44,677
-68,854
| -61% | -$32.8M |
|
168
Morgan Stanley
MS
$237B
| $21.1M | 0.14% |
222,431
-222,749
| -50% | -$21.1M |
|
169
Colgate-Palmolive
CL
$67.7B
| $21.1M | 0.14% |
259,143
+126,326
| +95% | +$10.3M |
|
170
Ambarella
AMBA
$3.36B
| $21M | 0.14% |
197,248
-55,014
| -22% | -$5.87M |
|
171
PNC Financial Services
PNC
$80.7B
| $20.7M | 0.14% |
108,608
+5,150
| +5% | +$982K |
|
172
Relay Therapeutics
RLAY
$709M
| $20.6M | 0.14% |
562,938
+562,927
| +5,117,518% | +$20.6M |
|
|
Y
173
DELISTED
Alleghany Corporation
Y
| $20.2M | 0.14% |
+25,082
| New | +$20.2M |
|
174
Apellis Pharmaceuticals
APLS
$3.51B
| $20.1M | 0.14% |
317,315
-238,059
| -43% | -$15M |
|
175
Curis
CRIS
$21.5M
| $20M | 0.14% |
2,480,163
+2,480,102
| +4,065,741% | +$20M |
|